| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Restricted Stock Units (RSU) | 22,997 | 04 Jan 2023 | Direct | ||
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Ordinary Shares | 0 | $116.50 | 06 Oct 2023 | Direct | |
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Ordinary Shares | 0 | $116.50 | 06 Oct 2023 | Indirect | |
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Performance Restricted Stock Units | 0 | 06 Oct 2023 | Direct | ||
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Restricted Stock Units | 0 | 06 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123052359-clayton-sean-m-2023-10-06 | Horizon Therapeutics Public Ltd Co | 06 Oct 2023 | 7 | -$978,600 | 4 | EVP, General Counsel | 06 Oct 2023, 17:51 |
| /report/000120919123016347-clayton-sean-m-2023-03-01 | Horizon Therapeutics Public Ltd Co | 01 Mar 2023 | 3 | -$775,911 | 4 | EVP, General Counsel | 06 Mar 2023, 15:52 |
| /report/000120919123002429-clayton-sean-m-2023-01-04 | Horizon Therapeutics Public Ltd Co | 04 Jan 2023 | 1 | $0 | 4 | EVP, General Counsel | 06 Jan 2023, 16:35 |
| /report/000120919122044796-clayton-sean-m-2022-08-04 | Horizon Therapeutics Public Ltd Co | 04 Aug 2022 | 1 | +$49,669 | 4 | EVP, General Counsel | 08 Aug 2022, 16:18 |
| /report/000120919122014699-clayton-sean-m-2022-03-01 | Horizon Therapeutics Public Ltd Co | 01 Mar 2022 | 1 | $0 | 4 | EVP, General Counsel | 02 Mar 2022, 15:11 |
| /report/000120919122014679-clayton-sean-m-2022-03-01 | Horizon Therapeutics Public Ltd Co | 01 Mar 2022 | 0 | $0 | 3 | EVP, General Counsel | 02 Mar 2022, 15:07 |